<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171007036599N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-25</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of aromatherapy with Rosa ِdamascenes on the sleep state of premature neonates</public_title>
      <acronym></acronym>
      <scientific_title>The effect of aromatherapy with Rosa damascenes on the sleep state of premature neonates admitted to the neonatal intensive care unit of Ali ebne Abitaleb hospital in Zahedan ,2020</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44937</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The permuted block stratified randomization method will be used. The stratified randomization method allows the elimination of possible heterogeneities between the two groups in terms of age and sex.
Also, the block randomization method provides the possibility of creating a balance in the number of samples assigned to each of the study groups. The randomization method is that the participating infants are classified at the beginning of the arrival in terms of age (30-33 and 33-37 weeks) and sex (girl-boy).
In the next step, the infants will be assigned individually to group A or B according to the quadruple blocks. Random sequence of quadruple blocks will be selected as ABAB / ABBA / BAAB / BABA / AABB / BBAA from the random number table. The classification and blocking process will continue until the study sample size is reached, Blinding description: In this research,sampling and intervention will be done with the help of the researcher. All interventions will be recorded by the video camera . First, the researcher will be placed on the newborn's bed to evaluate and complete the form while examining the infant's sleep status and then the researcher will review the film's information to confirm the accuracy and the final score will be given. Researchers are unaware of the newborn's sleeping position on the  newborn's bed , as well as the researcher's help when watching the recorded video of the intervention and control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Premature neonate's sleep.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:The baby is placed embryonically  in the nest inside a double-walled incubator. The type of sleeping position of the baby within 20 minutes, according to the Ales tool, is determined every 2 minutes before, during and after placing the pad soaked in Zahra's organic rose at a distance of 30 cm from the baby's head and is recorded in the table. Intervention 2: Control group:The baby is placed embryonically  in the nest inside a double-walled incubator. The type of sleeping position of the baby within 20 minutes, according to the Ales tool, is determined every 2 minutes before, during and after placing the pad soaked in" Distilled water" at a distance of 30 cm from the baby's head and is recorded in the table.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The main outcomes of the participants are public.

When:
The main outcomes of the participants are public.

To whom:
The researchers in academic and scientific institutions.

Conditions:
The statistical result.

Where to obtain:
Faculty of Nursing and Midwifery, Zahedan Telephone: 05433442481 Postcode: 9816913396 Address: Mashahir Square, Nursing and Midwifery Faculty, Zahedan

How to obtain:
Contact the Nursing Faculty Library section.

Comments:
does not have.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fereshteh Ghaljaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashahir square, Faculty of Nursing and Midwifery, Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816913396</zip>
        <telephone>+98 54 3344 2481</telephone>
        <email>Ghaljaei-f@zaums.ac.ir</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fereshteh Ghaljaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashahir square, Faculty of Nursing and Midwifery, Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816913396</zip>
        <telephone>+98 54 3344 2481</telephone>
        <email>Ghaljaie-f@zaums.ac.ir</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 30 and 37 fetal weeks
Sustainable physiological symptoms
Lack of severe respiratory distress
No history of drug abuse in the mother
Completion of the infant consent form for participation in research by parents</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>28 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a chest tube and a umbilical catheter
Use of narcotic, sedative and anesthetic drugs for the neonate
Having diseases: icterus, congenital neurological abnormalities, meningitis, seizures, encephalopathy and interstitial hemorrhage</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Extremely low birth weight newborn</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:The baby is placed embryonically  in the nest inside a double-walled incubator. The type of sleeping position of the baby within 20 minutes, according to the Ales tool, is determined every 2 minutes before, during and after placing the pad soaked in Zahra's organic rose at a distance of 30 cm from the baby's head and is recorded in the table.</i_keyword>
      <i_keyword>Control group:The baby is placed embryonically  in the nest inside a double-walled incubator. The type of sleeping position of the baby within 20 minutes, according to the Ales tool, is determined every 2 minutes before, during and after placing the pad soaked in" Distilled water" at a distance of 30 cm from the baby's head and is recorded in the table.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep status of preterm neonate. Timepoint: During 20 minutes before the intervention, 70 minutes during intervention and 20 minutes after the intervention. Method of measurement: Observation the behavior of neonate with use of sleep and waking scale of Als, by researcher and helpre.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Physiological signs of the neonate. Timepoint: Before, during and after the intervention. Method of measurement: Pulse oximetry.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences and Health Services</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-11-18</approval_date>
        <contact_name>Ethics Committee of Zahedan University of Medical Sciences</contact_name>
        <contact_address>Dr. Hassabi Square, Janat Blvd, Zahedan University of Medical Sciences Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
